EnglishFrenchGermanPortugueseSpanish

SCOTTISH AND UK GOVERNMENTS HAIL PROGRESS ON TRANSFORMATIONAL ABERDEEN BIOHUB

ONE-led £40m project will make Aberdeen “one of the UK’s most dynamic life sciences locations”

Monday, June 28, 2021
Cabinet Secretary for Finance, Kate Forbes MSP, and Chancellor of the Duchy of Lancaster and Minister for the Cabinet Office, The Rt Hon Michael Gove MP, today (Monday, 28 June) joined Opportunity North East Chairman, Sir Ian Wood KT GBE, and Aberdeen City Region Deal partners and main contractor Robertson Construction for a steel signing ceremony to mark significant construction progress on Aberdeen’s new-build BioHub.

BioHub, scheduled to open in October 2022, will house up to 400 scientific entrepreneurs with the goal of doubling the number of life sciences companies in the region by 2027. It will be home to spinout, start-up and scaling businesses bringing new drugs, treatments, therapies and technology to market and creating high-skill jobs to drive economic recovery in this fast-growing industry sector.

BioHub is a flagship addition to the city’s Foresterhill Health Campus, one of Europe’s largest integrated clinical, research and teaching sites for life sciences and medicine and will catalyse further collaborative innovation across the academic, commercial, and healthcare community.

Around 800 tonnes of steel frame has been installed on the BioHub site since main construction started at the end of March – equalling 1,600 pieces of steel lifted in by two cranes over 10 weeks.

Opportunity North East is the lead partner and a funder for the project, which has secured £20 million of capital funding jointly provided by the Scottish Government and UK Government via the Aberdeen City Region Deal.

Chairman of Opportunity North East, Sir Ian Wood, said: “BioHub is an iconic and truly transformational project that will deliver a huge boost to north east Scotland’s life sciences sector and contribute to the region’s economic recovery by creating jobs and providing the commercial infrastructure to support and attract businesses.
Today’s steel signing marks a significant milestone for BioHub and I am delighted to be joined by senior Ministers of both the Scottish and UK Governments. Their continued backing for the project is a massive vote of confidence in our ambition to make Aberdeen one of the UK’s most dynamic locations for life sciences company creation and growth.”

Finance and Economy Secretary Kate Forbes said: "The life sciences sector is a thriving part of Scotland’s economy, growing at more than 10% a year, providing more than 41,000 jobs and on target to achieve £8 billion turnover by 2025. North east Scotland has a distinctive industry cluster focusing on biotherapeutics and digital health, which are significant areas for growth. The Scottish Government investment in BioHub through the Aberdeen City Region Deal will support business creation, bring innovative healthcare solutions to market and deliver new jobs as part of the green economic recovery. This is a crucial time for business, trade and investment in Scotland and investing in our communities will ensure every part of Scotland recovers from the pandemic, helping build an economy for everyone.”

UK Government Minister for the Cabinet Office and Chancellor of the Duchy of Lancaster Michael Gove said: “The BioHub will deliver a world-class facility to support new business start-ups and expand Scotland’s powerhouse of life sciences innovation. This will bring new jobs to the region and build its global reputation as a place for companies to set up and invest. Across Scotland the UK Government is investing more than £1.5 billion into City Region and Growth Deal projects, helping communities to build back better from the pandemic.”

Professor Stephen Logan, Chair of BioAberdeen Limited and ONE Life Sciences, said: “This is a hugely exciting time for life sciences in Aberdeen. We are investing in building the sector network and pipeline of new starts and spinouts, based on the research and innovation within our universities and NHS. The sector’s profile is higher than ever before because of its role in tackling Covid-19. And our research strengths – including biologics and digital health – are industry investment priorities. Life sciences businesses in the region are excited to see BioHub progressing at pace and demand for specialist incubation, grow-on and laboratory accommodation is at an all-time high. BioHub will be a catalyst for growth.”

Lesley Meldrum, NHS Grampian's Head of Innovation Communications, said: "Having the BioHub on our very own Foresterhill Campus absolutely cements the North East's commitment to innovation across healthcare, academia and industry. This truly is an exciting time for innovation in Scotland and beyond."

Professor George Boyne, Principal and Vice-Chancellor of the University of Aberdeen, said: “As a delivery partner for the Aberdeen BioHub we are delighted to mark this new milestone in its development. The pandemic has brought into sharp focus the need for the University to play an enhanced role in the recovery and development of the north east of Scotland. Our partnership with BioHub will play an important role in this effort, and will add to our existing work on entrepreneurship, start-ups, consultancy and commercialisation. We look forward to working closely with BioHub partners to ensure that our research and innovation can make a significant contribution to the post-pandemic recovery.”

Councillor Andy Kille, Chair of the Aberdeen City Region Deal Joint Committee, said: “BioHub has been developed with industry to provide leaders in new, early-stage and established businesses with specialist facilities and support to grow and stay in the region. With the backing of the Aberdeen City Region Deal, BioHub will help businesses create new jobs and support a broader economic base for north east Scotland.”

Councillor Jenny Laing, Vice-Chair of the Aberdeen City Region Deal Joint Committee said: “Aberdeen has distinct research and innovation strengths in life sciences - across our companies, universities and NHS – and a track record of producing exciting new businesses. BioHub builds on these qualities to support growing life sciences businesses, create jobs and turn ideas into drugs, treatments and products. It is a landmark investment in life sciences and the sector’s role in the city region’s future economy.”

CEO of Robertson Group, Elliot Robertson, said: “This effective partnership between Opportunity North East, NHS Grampian, University of Aberdeen and Government is playing an instrumental role in the recovery, diversification and transformation of Aberdeen by growing the health economy, and we are proud to be the selected construction partner. The project is set to double the number of life science companies in north east Scotland and help the sector to collaborate, innovate and commercialise the next generation of therapies and healthcare solutions. The high-quality iconic building consisting of new innovative offices and lab spaces, will create a working environment that will influence and inspire the scientific entrepreneurs who will take up residence in late 2022.”

Success Stories

The Aberdeen City Region is primed for business and Invest Aberdeen is here to help.
Contact us for information on what the region has to offer


Get In Touch
contact
Supported by
follow us